Specialty Pharmacy

Targeting a certain antioxidant protein reduces the aggressiveness of triple-negative breast cancer and increases its sensitivity to conventional anti-cancer drugs.

Individuals with hepatitis C virus genotypes 1-3 benefited from treatment with MK-3682B

Women with genetic variants had lower hepatitis C viral levels after childbirth.

Roberta Diaz Brinton, PhD, was granted $10.3 million to determine why women are more likely to develop Alzheimer’s disease.

IL-1 antagonists are traditionally used to treat patients with rheumatoid diseases.

Two TNF-inhibitors found equally effective treating RA patients.

Targeted personalized therapy in patients with diabetes can reduce the risk of developing cancer.

Surprising findings from a study revealed that losing weight may not help protect against liver and colon cancer.

Stability of exhausted T cells in mice effects the durability of reinvigoration by PD-1 blockade.

Highly active antiretroviral therapy (HAART) prolongs survival for patients with HIV, but increases the risk for other chronic diseases.

The FDA has announced a new research model that may expedite research and development for a Zika virus vaccine.

Clinical outcomes have different meanings among specialty pharmacy stakeholders.

Researchers able to predict treatment response to TNFI drugs and rituximab in RA patients.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Top news of the day from across the health care landscape.

Two existing drugs, Gemcitabine and DON, target the degradation of nucleotides in the liver.

Growing evidence points to the relationship between rheumatoid arthritis and heart problems.

African Americans have the most severe burden of HIV in the United States.

Top news of the week in oncology and cancer drug development.

Promising data on pediatric relapsed/refractory acute lymphoblastic leukemia to be presented.

Researchers have identified an antibody that can neutralize 98% of HIV strains, and may serve as a potential candidate for future HIV treatment and prevention.

Cognitive and physical fitness may play a role in the development of ALS.

Top news of the week on Specialty Pharmacy Times.

Targeting TAZ can essentially stop fibrosis and may provide future treatment options for patients with nonalcoholic steatohepatitis.

Top news of the day from across the health care landscape.

Patients with rheumatoid arthritis want a fast-acting, orally administered treatment for their symptoms.

A better understanding of the mechanisms of arthritis is needed to develop superior treatments.

Viral loads were reduced in SIV-infected rhesus monkeys given an experimental vaccine in combination with an immune stimulant.